Skip to main content
. 2016 Aug 29;7(42):67748–67759. doi: 10.18632/oncotarget.11682

Table 5. NRI analysis for HE4.

NRI analysis for HE4
Model without HE4 Model with HE4 Reclassified
<50% 50-80% >80% Total Increased risk Decreased risk Net correctly reclassified
Patients with renal fibrosis
<50% 0 (0.00) 1 (100.00) 0 (0.00) 1 20 5 15
50-80% 3 (13.04) 1 (4.35) 19 (82.61) 23
>80% 2 (0.93) 0 (0.00) 213 (99.07) 215
Total 5 2 232 239
Patients without renal fibrosis
<50% 1 (100.00) 0 (0.00) 0 (0.00) 1 0 17 −17
50-80% 9 (81.81) 2 (18.18) 0 (0.00) 11
>80% 5 (62.5) 3 (37.5) 0 (0.00) 8
Total 15 5 0 20
*Data are frequency (row percentage). NRI=0.91 (P<0.01)